Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin for upper limb paresis
2015-001402-34Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of neuronox in upper extremity paresis, sponsored by Centre Hospitalier Universitaire de Brest. Started Oct 2016; status: active.
02
Drugs
neuronox
03
Conditions
upper extremity paresis
Beyond the preview
Go deeper on 2015-001402-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001402-34.